The fund will target early-stage digital health applications, medical devices and therapeutics developed on the Anschutz Medical Campus.
University of Colorado (CU)’s Anschutz Medical Campus yesterday closed a $50m healthcare-oriented fund with commitments from multiple university departments and affiliates.
CU Healthcare Innovation Fund has been backed by University of Colorado along with its healthcare system UCHealth, medical school CU Medicine and Children’s Hospital Colorado. All the LPs have a presence at Anschutz Medical Campus.
The vehicle funds early-stage healthcare businesses such as spinouts with a link to at least one of its partners, with a focus on digital health, healthcare IT, drug development and medical devices.
The goal is to improve patient outcomes by leveraging the stack of data now produced within healthcare, leading to better care provision and lead generation for new drugs. The fund has not revealed the size of investments it plans to make.
CU Healthcare Innovation’s portfolio already contains eight investees, including remote patient monitoring platform BioIntelliSense, prescription decision support…
